The economic cost of arthritis in New Zealand in 2018
Arthritis New Zealand
Deloitte Access Economics was commissioned by Arthritis New Zealand to estimate the economic cost of arthritis in New Zealand in 2018. This analysis is the third in a series of reports on the economic cost of arthritis in New Zealand, following on from the reports prepared by Access Economics in 2005 and 2010.
Arthritis is a long-term condition which can have a substantial impact on quality of life. It is an umbrella term used to describe a range of conditions affecting joints.
The total cost of arthritis in New Zealand is estimated to be $12.2 billion in 2018. The costs of arthritis comprise both financial costs, which include health sector costs, productivity losses and the cost of caring for people with arthritis, as well as loss of wellbeing for people with arthritis.